Pacific Capital Wealth Advisors, Inc Vertex Pharmaceuticals Inc Transaction History
Pacific Capital Wealth Advisors, Inc
- $592 Million
- Q3 2024
A detailed history of Pacific Capital Wealth Advisors, Inc transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Pacific Capital Wealth Advisors, Inc holds 38 shares of VRTX stock, worth $17,024. This represents 0.0% of its overall portfolio holdings.
Number of Shares
38
Previous 30
26.67%
Holding current value
$17,024
Previous $14,000
21.43%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding VRTX
# of Institutions
1,721Shares Held
222MCall Options Held
1.58MPut Options Held
1.36M-
Capital World Investors Los Angeles, CA26.8MShares$12 Billion1.99% of portfolio
-
Vanguard Group Inc Valley Forge, PA23.2MShares$10.4 Billion0.2% of portfolio
-
Black Rock Inc. New York, NY21.3MShares$9.55 Billion0.23% of portfolio
-
State Street Corp Boston, MA11.8MShares$5.29 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA9MShares$4.03 Billion0.9% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $115B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...